Article Versions Notes

Khan TZ, Hartley A, Haskard D, Caga-Anan M, Pennell DJ, Collins P, Barbir M, Khamis R. Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a). Antioxidants. 2021; 10(1):132. https://doi.org/10.3390/antiox10010132

Khan, Tina Z., Adam Hartley, Dorian Haskard, Mikhail Caga-Anan, Dudley J. Pennell, Peter Collins, Mahmoud Barbir, and Ramzi Khamis. 2021. "Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)" Antioxidants 10, no. 1: 132. https://doi.org/10.3390/antiox10010132

Khan, T. Z., Hartley, A., Haskard, D., Caga-Anan, M., Pennell, D. J., Collins, P., Barbir, M., & Khamis, R. (2021). Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a). Antioxidants, 10(1), 132. https://doi.org/10.3390/antiox10010132